de Montmollin, E.; Peoc’h, K.; Marzouk, M.; Ruckly, S.; Wicky, P.-H.; Patrier, J.; Jaquet, P.; Sonneville, R.; Bouadma, L.; Timsit, J.-F.
Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS. Antibiotics 2022, 11, 1166.
https://doi.org/10.3390/antibiotics11091166
AMA Style
de Montmollin E, Peoc’h K, Marzouk M, Ruckly S, Wicky P-H, Patrier J, Jaquet P, Sonneville R, Bouadma L, Timsit J-F.
Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS. Antibiotics. 2022; 11(9):1166.
https://doi.org/10.3390/antibiotics11091166
Chicago/Turabian Style
de Montmollin, Etienne, Katell Peoc’h, Mehdi Marzouk, Stéphane Ruckly, Paul-Henri Wicky, Juliette Patrier, Pierre Jaquet, Romain Sonneville, Lila Bouadma, and Jean-François Timsit.
2022. "Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS" Antibiotics 11, no. 9: 1166.
https://doi.org/10.3390/antibiotics11091166
APA Style
de Montmollin, E., Peoc’h, K., Marzouk, M., Ruckly, S., Wicky, P.-H., Patrier, J., Jaquet, P., Sonneville, R., Bouadma, L., & Timsit, J.-F.
(2022). Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS. Antibiotics, 11(9), 1166.
https://doi.org/10.3390/antibiotics11091166